3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
10
Phase 1
4
Phase NA
3
Phase 1/2
3
Phase 3
2
Status
Completed
20
Recruiting
8
Terminated
7
Active not recruiting
6
Not yet recruiting
5
Unknown
4
Withdrawn
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Tumor-Agnostic
1
Conditions
Breast Neoplasms
25
Neoplasms
19
Prostatic Neoplasms
15
Carcinoma, Non-Small-Cell Lung
15
Carcinoma, Hepatocellular
10
Urinary Bladder Neoplasms
8
Ovarian Neoplasms
8
Head and Neck Neoplasms
8
Pain
7
Lung Neoplasms
7
Leukemia, Myeloid, Acute
7
Squamous Cell Carcinoma of Head and Neck
6
Neoplasm Metastasis
6
Lymphoma, Follicular
6
Leukemia
6
Uterine Cervical Neoplasms
5
Stomach Neoplasms
5
Recurrence
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Non-Muscle Invasive Bladder Neoplasms
5
Brain Neoplasms
5
Small Cell Lung Carcinoma
4
Multiple Myeloma
4
Lymphoma, Non-Hodgkin
4
Lymphoma
4
Leiomyoma
4
Carcinoma
4
Urologic Neoplasms
3
Urogenital Neoplasms
3
Papillomavirus Infections
3
Interventions
Radiotherapy, Intensity-Modulated
1
Morphine
1
Methadone
1
Heavy Ion Radiotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Withdrawn
×
Adenocarcinoma
×
Clear all
NCT05325164
2022-12-05
METHADOPT
Ottawa Hospital Research Institute
Phase 3
Withdrawn
NCT03536182
2021-05-26
CIPHER
University of Texas Southwestern Medical Center
Phase 3
Withdrawn